2022年欧洲生殖器官感染和肿瘤研究组织大会

EUROGIN 2022 - EUropean Research Organisation on Genital Infection and Neoplasia Congress

Date: April 10-13, 2022
Venue: Congress Center Düsseldorf, Germany

摘要征集：

ABSTRACT SUBMISSION DEADLINE: DECEMBER 1, 2021
Late breaker deadline : on request – strict conditions to be complied with.

All abstracts must be submitted through the online abstract submission system.

点此提交摘要>>>Submit Abstract>>>

Abstract topics

For review purposes, abstracts are classified according to the following list.

Select only 1 topic on our submission form:

1. HPV disease and COVID-19
   
2. Viral and molecular biology
3. Epidemiology and natural history
4. Pathogenesis
5. Immunology
6. HPV prophylactic vaccines
7. HPV therapeutic vaccines
8. Immunotherapy - Immuno-oncology - New treatments
9. HPV testing
10. HPV screening
11. Screening for women difficult to reach
12. Triage of HPV positive women
13. Self-sampling
14. Genotyping
15. Molecular markers
16. Screening methods
17. Automation in cytology
18. Methylation
19. Microbiome
20. Serology
21. New technologies
22. Artificial Intelligence
23. Diagnostic procedures / management
24. Risk management
25. Colposcopy
26. Cervical neoplasia
27. Vulvar and vaginal diseases and neoplasia
28. Anal neoplasia
29. Oral HPV infection
30. HPV and oropharynx / Head and neck cancer
31. HPV and associated skin diseases
32. Genital warts
33. HPV transmission
34. Sexually transmitted diseases and HIV infection
35. Conventional therapies
36. Economics and modelling
37. Advocacy, acceptability and psychology
38. Health education
39. Low resource settings
40. Public health
41. Fertility and HPV

Message from the Chairman of the Scientific Committee

Dear friends and colleagues,

Since its creation three decades ago, the EUROGIN congress has gained a strong reputation as one of the leading international conferences on HPV infection and associated cancers. The meeting offers a forum for high-level scientific exchange involving multiple disciplines, with the aim to translate research into clinical practice. Thanks to the top-ranking program committee the congress program offers up-to-date scientific information on the full range of HPV-related diseases.

For non-vaccinated populations, early detection and HPV based screening remains to be the key challenge.

The perspective of eliminating HPV infection and related cancers continues to be a major goal. HPV immunization on a large scale opens a priceless opportunity to reduce the burden of cervical, ano-genital and oral cancer all over the world. The journey started some time ago, but the destination has now come into sight: elimination of HPV related cancer.

As usual, the EUROGIN congress will offer a variety of educational opportunities for attendees: training courses, specialized workshops, scientific sessions, clinical sessions, free communications and poster presentations.

On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to EUROGIN.

Joseph Monsonego
Chairman of the Scientific Committee